William E. Boden, MD

Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

I am ABIM board-certified in both Internal Medicine and the subspecialty of Cardiovascular Disease. Since 1979, I have held university appointments at Brown University, Wayne State University, Tufts New England Medical Center, Boston University, the University of Connecticut, State University of New York in Buffalo, and Albany Medical College. For the past 27 consecutive years, I have held leadership roles as either a Chief of cardiology or Chief of Medicine at both federal VA facilities and in the academic private sector, all of which have had strong affiliations with their respective academic health centers. In 2016, I re-joined the VA Boston MAVERIC Center as the Scientific Director, Clinical Trials Network, for the VA New England Healthcare System, and as the Research Lead Physician, for VISN 1.

I have extensive prior experience in clinical trials and comparative effectiveness research, and have served in a leadership capacity in several important national and international clinical trials, including as Study Chair for VA CSP-funded VANQWISH and COURAGE Trials, as Study Co-Chair of the NIH-funded AIM-HIGH Trial, and as a national co-PI for the NIH-funded ISCHEMIA Trial. My principal research interests include studies in stable ischemic heart disease, post-MI secondary prevention, acute coronary syndromes, and preventive cardiology.

Publications

  • Published 9/5/2025

    Huded CP, Spertus JA, Jones PG, O'Brien SM, Mark DB, Bangalore S, Stone GW, Williams DO, White HD, Boden WE, Reynolds HR, Hochman JS, Maron DJ. Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA. Circulation. 2025 Sep 23; 152(12):846-858. PMID: 40910165.

    Read at: PubMed

  • Published 8/29/2025

    De Caterina R, Bhatt DL, Boden WE. Optimal medical therapy for initial management of stable angina: a call to action. Eur Heart J. 2025 Aug 29. PMID: 40878861.

    Read at: PubMed

  • Published 8/26/2025

    Barili F, Dib N, Redberg RF, Boden WE, Kaul S, Parolari A, Anselmi A. From the Hazards of Death to the Hazards of Indication Creep for TAVR. J Am Coll Cardiol. 2025 Aug 26; 86(8):e75-e76. PMID: 40835371.

    Read at: PubMed

  • Published 6/27/2025

    De Caterina R, Budoff M, Boden WE. Editorial: Therapeutic strategies to lower residual dyslipidemic CV risk beyond LDL-C and statins. Front Cardiovasc Med. 2025; 12:1597062. PMID: 40656769.

    Read at: PubMed

  • Published 6/24/2025

    Barili F, Pollari F, Marin-Cuartas M, Anselmi A, de la Cuesta M, Brophy JM, Boden WE, De Caterina R, Dayan V, Roda JR, Uva MS, Almeida RMS, Tomasi J, Verhoye JP, Musumeci F, Mandrola J, Kaul S, Papatheodorou S, Parolari A. Time-to-event analysis of the long-term outcome in trials comparing transcatheter and surgical aortic valve implantation: A meta-analysis. Int J Cardiol. 2025 Nov 01; 438:133524. PMID: 40571128.

    Read at: PubMed

Other Positions

  • Lecturer in Medicine
    Harvard Medical School
  • Physician Research Lead & Scientific Director, MAVERIC Center
    VA Boston Healthcare System

Education

  • State University of New York at Brockport, MD
  • Le Moyne College, BS